Literature DB >> 19494653

Neuroprotection for diabetic retinopathy.

Hisanori Imai, Ravi S J Singh, Patrice E Fort, Thomas W Gardner.   

Abstract

Diabetic retinopathy (DR) is a neurodegenerative and microvascular disease resulting in functional and structural changes of all cell types in the retina. Several mechanisms for neuroretinal homeostasis, including the blood-retinal barrier, normal metabolite delivery into the retina, and the effect of neurotrophins for the retina, are impaired in DR. However, it is still not clear which components are most important for the development of DR and which may be most useful as therapeutic targets. In this chapter, we summarize the evidence for the neurodegeneration in DR and review normal mechanisms for maintenance of postmitotic cells in the retina and alterations in normal maintenance pathways in DR with emphasis on 'neuroprotection'. Finally, we discuss current neuroprotective strategies and future directions for the treatment of DR. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494653     DOI: 10.1159/000223946

Source DB:  PubMed          Journal:  Dev Ophthalmol        ISSN: 0250-3751


  15 in total

1.  Early neurodegeneration in the retina of type 2 diabetic patients.

Authors:  Hille W van Dijk; Frank D Verbraak; Pauline H B Kok; Marilette Stehouwer; Mona K Garvin; Milan Sonka; J Hans DeVries; Reinier O Schlingemann; Michael D Abràmoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-14       Impact factor: 4.799

Review 2.  Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.

Authors:  S Priya Narayanan; Esraa Shosha; Chithra D Palani
Journal:  Pharmacol Res       Date:  2019-06-15       Impact factor: 7.658

3.  Visual sensitivity loss in the central 30° of visual field is associated with diabetic peripheral neuropathy.

Authors:  G P Sampson; A M Shahidi; D Vagenas; N Pritchard; K Edwards; A W Russell; R A Malik; N Efron
Journal:  Diabetologia       Date:  2012-01-19       Impact factor: 10.122

4.  Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus.

Authors:  Elliott H Sohn; Hille W van Dijk; Chunhua Jiao; Pauline H B Kok; Woojin Jeong; Nazli Demirkaya; Allison Garmager; Ferdinand Wit; Murat Kucukevcilioglu; Mirjam E J van Velthoven; J Hans DeVries; Robert F Mullins; Markus H Kuehn; Reinier Otto Schlingemann; Milan Sonka; Frank D Verbraak; Michael David Abràmoff
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

5.  Protective and antioxidant effects of PPARα in the ischemic retina.

Authors:  Elizabeth Moran; Lexi Ding; Zhongxiao Wang; Rui Cheng; Qian Chen; Robert Moore; Yusuke Takahashi; Jian-xing Ma
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-13       Impact factor: 4.799

6.  Prediction of diabetic retinopathy: role of oxidative stress and relevance of apoptotic biomarkers.

Authors:  Mohamed Al-Shabrawey; Sylvia Smith
Journal:  EPMA J       Date:  2010-03-23       Impact factor: 6.543

7.  The unconventional role of acid sphingomyelinase in regulation of retinal microangiopathy in diabetic human and animal models.

Authors:  Madalina Opreanu; Maria Tikhonenko; Svetlana Bozack; Todd A Lydic; Gavin E Reid; Kelly M McSorley; Andrew Sochacki; Gloria I Perez; Walter J Esselman; Timothy Kern; Richard Kolesnick; Maria B Grant; Julia V Busik
Journal:  Diabetes       Date:  2011-07-19       Impact factor: 9.461

Review 8.  Clinical biomarkers and molecular basis for optimized treatment of diabetic retinopathy: current status and future prospects.

Authors:  Rohit Saxena; Digvijay Singh; Ravi Saklani; Suresh Kumar Gupta
Journal:  Eye Brain       Date:  2016-02-19

9.  The db/db mouse: a useful model for the study of diabetic retinal neurodegeneration.

Authors:  Patricia Bogdanov; Lidia Corraliza; Josep A Villena; Andrea R Carvalho; José Garcia-Arumí; David Ramos; Jesús Ruberte; Rafael Simó; Cristina Hernández
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

10.  VEGF-B inhibits hyperglycemia- and Macugen-induced retinal apoptosis.

Authors:  Delong Huang; Chen Zhao; Rong Ju; Anil Kumar; Geng Tian; Lijuan Huang; Lei Zheng; Xianglin Li; Lixian Liu; Shasha Wang; Xiangrong Ren; Zhimin Ye; Wei Chen; Liying Xing; Qishan Chen; Zhiqin Gao; Jia Mi; Zhongshu Tang; Bin Wang; Shuping Zhang; Chunsik Lee; Xuri Li
Journal:  Sci Rep       Date:  2016-05-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.